We are NeLL
and we are
healthcare of
the future.

About NeLL

The National eHealth Living Lab (NeLL) is building a collaborative community that is focused on new e-Health-tools and their further development.

NeLL offers an interactive platform where healthcare consumers and professionals, the business community and public organisations make contact to share knowledge, information and experience. The platform online and interactive, combining the website with in-person meetings, including workshops, expert panels, etc.

NeLL serves as a showcase for sharing information about relevant eHealth projects. The aim is to provide insight into what is being developed and where opportunities still lie, helping avoid fragmentation. It also enables community members to interact with the network and to showcase their own, or their organisation’s experience and expertise.

At NeLL, we consider co-creation (with the end user - patient and/or healthcare provider) essential in the development of useful new healthcare applications. We also believe it is imperative that eHealth tools are subjected to scientific research so that we can prove what is expedient and what is not.

It is an open platform: open to anyone associated with or interested in eHealth. NeLL is committed to open source and open science, which means that we share all insights.

Ultimately we aim to realise scientifically-proven, effective eHealth applications in order to enable them to become a fully-integrated part of effective healthcare and to upscale these tools in the Netherlands and internationally. In doing so, we are improving and future-proofing healthcare.


NeLL is an open network open to anyone associated with or interested in eHealth. At the heart of the community, ‘Bureau NeLL’ can help you find the right specialists, involve the patient, establish contacts and organise events.


NeLL projects criteria

NeLL can launch a new eHealth project independently or in collaboration with others. A project is ‘NeLL Compatible’ when it meets the criteria outlined below.
The basic principles for a NeLL Compatible project:

Focus on the end user

End users are involved at all times in the development of ideas, concepts, products and services in order to ensure that the application developed addresses the need and has a positive impact.


The application is can scale up with the Netherlands and/or internationally.

Proven impact

The eHealth tool is supported with scientific research and has proven impact.


There is transparent communication on the progress of all NeLL projects and the scientific research on the NeLL website, social media and in publications.

NeLL Board of Directors

Prof Niels H. Chavannes, MD PhD
  • Professor in general practice at LUMC
  • Chair in eHealth applications in disease management
  • Head of research, public and first-line healthcare department at LUMC
  • National adviser on action programme on chronic pulmonary diseases
  • Member of WHO-GARD
Esther Talboom-Kamp, MD MBA PhD
  • Chairman of the Board of Directors at Saltro
  • Researcher at LUMC
  • Board member of InEen & Zelfzorg Ondersteund
Prof Douwe Atsma, MD PhD
  • Professor of Cardiology at LUMC
Fred Boer, PhD
  • Head of Healthcare Innovation at LUMC

Case studies

NeLL compatible
GGD AppStore

Apps offered in a range of app stores focusing on health and/or care are validated in terms of effectiveness, reliability and safety.

“Around 325,000 apps are available and hardly any of them have been proven to be effective. This needs to change so that consumers and patients can be sure that they are actually being helped by the app they are using.” - Niels Chavannes

The Box

A box featuring wearables for patients who have recently suffered an acute heart attack. The Box contains instruments that patients can use to monitor their own condition. The doctor also views the information, analyses the patient data and provides support and supervision remotely or if necessary at the clinic.

Scientific research shows that, compared to standard care:

  1. blood pressure is better regulated;
  2. arrhythmia is more likely to be detected and treated if necessary;
  3. quality of life is improved and
  4. the number of adverse effects in the first year after the attack is reduced.

“The Box puts the patient first, motivating him or her to take control over both disease and lifestyle. Research indicates a high level of patient satisfaction: 95%. After a year, the patient’s condition stabilises, enabling him/her to be treated by the GP instead of the hospital. This also has economic advantages. With the Box, we are offering the right care in the right place.” - Douwe Atsma

Saltro Directlab

Sexually-transmitted infections (STIs) are still often associated with a sense of shame. People who suspect they may be infected can be reluctant to visit their GP. They can now turn to Saltro Directlab. An online questionnaire is used to investigate whether it is advisable to get tested. If testing is recommended, a reliable self-testing kit can be purchased in the webshop. The examination is similar to that conducted by the GP. Results are shared with the customer discreetly and, if desired, passed on to the GP in order to enable a decision to be agreed with the doctor on the best course of treatment.

“Via Directlab, we aim to offer everyone access to reliable self-tests. Taboos or shame must not be allowed to result in unnecessary diseases or far-reaching consequences from disorders that are relatively easy to treat. We started out in the Netherlands, but see lots of opportunities on the international market where society is less open or where STI self-tests are difficult to obtain.” - Esther Talboom-Kamp


Prof Niels H. Chavannes, MD PhD

Most recent scientific publications:

  • Effect of a workplace-based group training programme combined with financial incentives on smoking cessation: a cluster-randomised controlled trial. | DOI: 10.1016/S2468-2667(18)30185-3
  • A systematic diagnostic evaluation combined with an internet-based self-management support system for patients with asthma or COPD. | DOI: 10.2147/COPD.S175361
  • Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. | DOI:  10.1016/j.jaci.2018.08.049

Esther Talboom-Kamp, MD, MBA, PhD

Most recent scientific publications:

  • Personal care with e-health | DOI:10.1007/s12445-018-0344-4
  • Effect of a combined education and eHealth programme on the control of oral anticoagulation patients (PORTALS study): a parallel cohort design in Dutch primary care. | DOI: 10.1136/bmjopen-2017-017909
  • The Effect of Integration of Self-Management Web Platforms on Health Status in Chronic Obstructive Pulmonary Disease Management in Primary Care (e-Vita Study): Interrupted Time Series Design. | DOI: 10.2196/jmir.8262

Prof Douwe Atsma, MD PhD

Most recent scientific publications:

  • Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response. | DOI: 10.1038/s41598-018-25143-y
  • Using Smart Technology to Improve Outcomes in Myocardial Infarction Patients: Rationale and Design of a Protocol for a Randomized Controlled Trial, The Box. | DOI: 810.2196/resprot.803
  • Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation. | DOI: 10.1161/CIRCEP.116.004052

Full project list and bibliography available on request.


For media & partnerships please contact:

Like to learn more about NeLL and how we can work together? Drop us a note via

Cherelle de Graaf

Strategic Manager

06 11 03 02 49